Early presentation of allergic contact dermatitis due to paraphenylenediamine.

IF 2.5 4区医学 Q3 ALLERGY

Allergologia et immunopathologia Pub Date : 2024-01-01 DOI:10.15586/aei.v52i1.899

Irene Andrés Alberola, Eva Jiménez Hernández, José F Soltero Carracedo, Alba Macías Panedas, Natalia Martín Iranzo, María Bartolomé Morate, Susana Alberola López, Jesús Rodríguez Calleja

{"title":"Early presentation of allergic contact dermatitis due to paraphenylenediamine.","authors":"Irene Andrés Alberola, Eva Jiménez Hernández, José F Soltero Carracedo, Alba Macías Panedas, Natalia Martín Iranzo, María Bartolomé Morate, Susana Alberola López, Jesús Rodríguez Calleja","doi":"10.15586/aei.v52i1.899","DOIUrl":null,"url":null,"abstract":"<p><p>Allergic contact dermatitis (ACD) is a more frequent pathology in adults than in children, because, in most cases, allergic sensitization requires a prolonged exposure time to the allergen, mostly months or years. In fact, the actual incidence and prevalence of ACD in children and adolescents is unknown. However, there is a hypothesis that ACD is increasing in the pediatric population. Among the allergens involved in ACD, the frequency of paraphenylenediamine (PPDA) is increasing. PPDA is one of the five most common contact allergens in the general population and one of the 10 most common contact allergens in children. The most relevant sources today are henna tattoos and hair dyes. Currently, European Union legislation limits the use of PPDA in hair dyes and prohibits its use in henna tattoos. Despite this legislation, the use of henna tattoos with PPDA is becoming more frequent in younger ages. We report an early presentation of ACD by PPDA, with a permanent hypopigmented skin area as an aftermath, in a 7-year-old male child. We believe that health authorities should advise against making these tattoos in children.</p>","PeriodicalId":7536,"journal":{"name":"Allergologia et immunopathologia","volume":null,"pages":null},"PeriodicalIF":2.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologia et immunopathologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15586/aei.v52i1.899","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

Abstract

Allergic contact dermatitis (ACD) is a more frequent pathology in adults than in children, because, in most cases, allergic sensitization requires a prolonged exposure time to the allergen, mostly months or years. In fact, the actual incidence and prevalence of ACD in children and adolescents is unknown. However, there is a hypothesis that ACD is increasing in the pediatric population. Among the allergens involved in ACD, the frequency of paraphenylenediamine (PPDA) is increasing. PPDA is one of the five most common contact allergens in the general population and one of the 10 most common contact allergens in children. The most relevant sources today are henna tattoos and hair dyes. Currently, European Union legislation limits the use of PPDA in hair dyes and prohibits its use in henna tattoos. Despite this legislation, the use of henna tattoos with PPDA is becoming more frequent in younger ages. We report an early presentation of ACD by PPDA, with a permanent hypopigmented skin area as an aftermath, in a 7-year-old male child. We believe that health authorities should advise against making these tattoos in children.

查看原文本刊更多论文

对苯二胺引起的过敏性接触性皮炎的早期表现。

过敏性接触性皮炎（ACD）是一种成人比儿童更常见的病症，因为在大多数情况下，过敏性致敏需要长时间接触过敏原，多为数月或数年。事实上，ACD 在儿童和青少年中的实际发病率和流行率还不得而知。不过，有一种假设认为，ACD 在儿童人群中的发病率正在上升。在 ACD 所涉及的过敏原中，对苯二胺（PPDA）的出现频率正在增加。对苯二胺是普通人群中最常见的五种接触过敏原之一，也是儿童最常见的十种接触过敏原之一。目前最常见的过敏源是指甲花纹身和染发剂。目前，欧盟立法限制在染发剂中使用 PPDA，并禁止在指甲花纹身中使用 PPDA。尽管有这样的法律规定，但使用含有 PPDA 的指甲花纹身在年轻人中越来越常见。我们报告了一名 7 岁男童因使用 PPDA 而导致的早期 ACD，其后遗症是皮肤永久性色素减退。我们认为，卫生部门应建议不要在儿童身上进行此类纹身。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergologia et immunopathologia 医学-过敏

CiteScore

3.70

自引率

0.00%

发文量

131

审稿时长

6-12 weeks

期刊介绍： Founded in 1972 by Professor A. Oehling, Allergologia et Immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. Manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. Allergologia et Immunopathologia is the official journal of the Spanish Society of Pediatric Allergy and Clinical Immunology (SEICAP) and also of the Latin American Society of Immunodeficiencies (LASID). It has and independent international Editorial Committee which submits received papers for peer-reviewing by international experts. The journal accepts original and review articles from all over the world, together with consensus statements from the aforementioned societies. Occasionally, the opinion of an expert on a burning topic is published in the "Point of View" section. Letters to the Editor on previously published papers are welcomed. Allergologia et Immunopathologia publishes 6 issues per year and is included in the major databases such as Pubmed, Scopus, Web of Knowledge, etc.